Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
Separation Agreement with Former Chief Financial Officer
As previously disclosed on Aytu’s Current Report on Form 8-K filed on April 5, 2021, David A. Green resigned as the Chief Financial Officer, Secretary and Treasurer of the Company on March 31, 2021. On April 12, 2021, Aytu and Mr. Green entered into separation agreement, effective March 31, 2021, pursuant to which Mr. Green will receive payment for accrued but unused personal time off, a cash payment in lieu of equity, a separation payment of $550,000, COBRA coverage, a Merger bonus consisting of $100,000 cash plus $100,000 of Aytu common stock, and acceleration of any unvested options or restricted stock held by Mr. Green.
Employment Agreements
In connection with the Purchase Agreement, on April 12, 2021, Aytu entered in employment agreements with Christopher Brooke and Nathaniel Massari (collectively, the “Employment Agreements”).
The material terms of the Employment Agreements are as follows:
|
●
|
An annual base salary of $360,000, plus a target bonus of 40% of the base salary at the sole discretion of Aytu’s board of directors;
|
|
●
|
A restricted stock unit grant of 73,100 shares of Aytu’s common stock, subject to certain vesting provisions set forth therein;
|
|
●
|
Upon a termination without Cause by Aytu or for Good Reason by Mr. Brooke or Mr. Massari, as applicable, as those terms are defined in the Employment Agreements, , a severance payment equal to base salary plus any earned incentive compensation, as well as a continuation of Aytu’s portion of COBRA payments for a period of 12 months; and
|
|
●
|
Upon a Change in Control, as defined in the Employment Agreements, accelerated vesting of all stock options, restricted stock or stock-based awards, plus any other applicable payments due in the event of a termination, if applicable.
|
Aytu intends to file the Employment Agreements and other agreements referenced in this Current Report on Form 8-K with its next Quarterly Report on Form 10-Q.
Amendment of Chief Executive Officer Employment Agreement
On April 16, 2021, Aytu entered into an amendment (the “Amendment”) to the Employment Agreement with Joshua R. Disbrow (the “CEO Employment Agreement”), dated April 16, 2019. The Amendment was approved by the compensation committee of the Board on March 14, 2021.
The material terms of the Amendment are as follows:
|
●
|
Extend term of the CEO Employment Agreement to a term expiring 24 months from the date of the Amendment;
|
|
●
|
Grant of restricted stock equal to 3% of Aytu’s issued and outstanding stock and an additional future grant of 2% if certain performance standards are satisfied, as determined by the compensation committee of the Board;
|
|
●
|
Update the Change in Control definition to be consistent with the Sale Event definition in the Disbrow Restricted Stock Agreement (defined below).
|
Pursuant to the Amendment, on April 16, 2021, Aytu entered into a restricted stock award agreement (the “Disbrow Restricted Stock Award Agreement”) with Mr. Disbrow, pursuant to which Aytu granted 800,000 restricted shares of Aytu’s common stock (the “Disbrow Restricted Shares”) to Mr. Disbrow. Pursuant to the Disbrow Restricted Stock Award Agreement, one-third of the Disbrow Restricted Shares will vest on the one-year anniversary of the grant date, with one-twelfth of the Disbrow Restricted Shares to vest quarterly thereafter for a period of two years. In addition, vesting of the Disbrow Restricted Shares will accelerate in the following events: (a) the consummation of a Sale Event, as that term is defined in the Disbrow Restricted Stock Award Agreement, (b) the closing price of Aytu’s common stock is equal or greater to $40 per share for two consecutive trading days, (c) Mr. Disbrow’s service or employment is terminated by Aytu without Cause, as that term is defined in the Disbrow Restricted Stock Award Agreement or (d) at the discretion of the Compensation Committee of Aytu’s board of directors based on Aytu achieving certain revenue milestones and the successful integration of future acquisitions.
Restricted Stock Grants to Directors
On April 16, 2021, Aytu entered into restricted stock award agreements with the independent directors serving on Aytu’s board of directors prior to the closing of merger with Neos Therapeutics, Inc. (the “Merger”), previously disclosed on Aytu’s Current Report on Form 8-K filed on March 22, 2021 (the “Pre-Merger Independent Directors”), pursuant to which Aytu granted the Pre-Merger Independent Directors an amount of restricted stock equal to four percent of Aytu’s issued and outstanding equity as of the closing of the Merger, split equally among the Pre-Merger Independent Directors. Pursuant to the restricted stock award agreements with the Pre-Merger Independent Directors, one-third of the restricted shares granted to each director will vest on the one-year anniversary of the grant date, with one-twelfth of the restricted shares to vest quarterly thereafter for a period of two years. In addition, vesting of the restricted shares will accelerate in the following events: (a) the consummation of a Sale Event, as that term is defined in the restricted stock award agreements, (b) the closing price of Aytu’s common stock is equal or greater to $40 per share for two consecutive trading days or (c) a director’s service is terminated by Aytu without Cause, as that term is defined in the restricted stock award agreements. The foregoing equity grant was approved by the compensation committee of the Board on March 14, 2021.